Niti Aayog bats for GM seeds -Governance Now

Niti Aayog bats for GM seeds

Suggests limiting GM seeds to those varieties discovered by Indian institutions and companies.

GN Bureau | May 8, 2017

#growth #agriculture #seeds #genetically modified #Niti Aayog #action agenda

Niti Aayog is open to the idea of utilizing genetically modified (GM) seeds to help in agricultural growth.

The three year action agenda of Niti Aayog says, “Genetically modified (GM) seeds have emerged as a powerful new technology promising high productivity, improved quality and lower use of fertilizers, weedicides and pesticides in the last one to two decades. They have also gained increasing acceptance among farmers around the world. Indian farmers also enthusiastically embraced these seeds in the only crop in which they have been permitted so far: cotton.”

Read: GM Mustard is ready. But are we?

“There is some concern that GM seeds can be monopolized by multinationals, which may then exploit our farmers. But this concern is readily addressed by limiting GM seeds to those varieties discovered by our own institutions and companies,” it adds.

The Aayog says that technology in the form of high-yielding seeds and fertilizer were the driver of India’s attainment of self- sufficiency through the green revolution, and new technology remains one of the most important determinants of growth in agriculture. We need to work on several fronts.

“India needs a vibrant, responsive, market oriented and globally competitive agricultural research eco system. Instead of creating more institutions, quality must be attained through greater focus on fewer high quality institutions,” the Aayog adds.

Read: GM tech is already obsolete: Suman Sahai of Gene Campaign

Comments

Other News

How corporates can nudge real change

The Business Of Business Is (Not) Just Business: How Behavioural Tools Can Drive Real Change Edited by Sutapa Banerjee, with Foreword by Nadir Godrej HarperCollins, 336 pages, Rs 699

India stopped jailing people for paperwork. Now comes the hard part

A small pharmacist in Rajkot neglects to change a notice in his store under a little-known clause of a public health law. This was not only a non-compliance matter, but also a criminal offence, and a jail sentence was the punishment under the old system. Not a fine. Not a warning. Jail. Now scale

How to make our cities climate-resilient

Indian cities are growing at a pace that our infrastructure and climate can no longer sustain. This rapid urban sprawl increasingly strains urban systems, overshadowing the severe environmental fallout produced in its wake. The repercussions include Urban Heat Island Effect (UHI), Urban Floods, and many mo

Trump’s China setback pushes US to woo India

A week after Donald Trump’s visit to China – the first by an American president in nine years, US secretary of state Marco Rubio arrived in India on May 23 on a four-day visit aimed at resetting Washington DC’s relations with New Delhi and attending the third Quad ministerial meeting.

EU–India FTA 2026: A high‑stakes prescription for Indian pharma and healthcare

India’s pharmaceutical industry stands as one of the world’s market leaders of generic pharmacy with market valuation of USD 50 billion in 2026. Characterised by high volume, low-cost generic manufacturing, with an annual growth rate of 10-12% primarily propelled by exports and domestic demand,